The reagent kit is designed for non-invasive detection of the fetal Rh factor (RHD) gene in the blood plasma of an Rh-negative mother to predict the risk of developing Rh conflict and HDFN.
The testing kit is intended for non-invasive diagnosis of the sex of a child by detecting the sex gene (SRY) of the fetus in the blood plasma of a pregnant woman.
Detection of the SRY gene indicates a male fetus, if this gene was not detected, the fetus is female.